Skip to NavigationSkip to content

News

0
Will co-develop Xencor's two T-cell engaging bispecific antibodies targeting acute myeloid leukemia and B-cell malignancies  
0
Says US FDA granted priority review for Ocrevus BLA
0
Insulin is delivered using continuous infusion and is often used by people with type 1 diabetes
0
This is the sixth Breakthrough Therapy Designation for Opdivo

Features

Here’s a quick look at some of the biggest movers of the week: